Christian von Hehn

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

Samantha Budd Haeberlein, Paul Aisen, Frederik Barkhof et al. · The Journal of Prevention of Alzheimer s Disease · 2022 · 1.2K citations · Full text

Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation

Sébastien Talbot, Raja-Elie E. Abdulnour, Patrick R. Burkett et al. · Neuron · 2015 · 421 citations · Full text

5,6-EET Is Released upon Neuronal Activity and Induces Mechanical Pain Hypersensitivity via TRPA1 on Central Afferent Terminals

Marco Sisignano, Chul‐Kyu Park, Carlo Angioni et al. · Journal of Neuroscience · 2012 · 132 citations · Full text

Pain Medicine, Neuropathic Pain, Molecular Pain +20

Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome

Darin T. Okuda, Orhun H. Kantarci, Christine Lebrun‐Frénay et al. · Annals of Neurology · 2022 · 113 citations

Clinical Development of Aducanumab, an Anti-Aβ Human Monoclonal Antibody Being Investigated for the Treatment of Early Alzheimer's Disease.

Samantha Budd Haeberlein, John O’Gorman, Ping-Chun Chiao et al. · PubMed · 2017 · 86 citations

Amyloid β, Immunology, Neurochemical Biomarkers +18